COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,832 Articles (22,553 medRxiv, 8,279 bioRxiv)

Most recent first Previous |  Page 1660: Articles 16591-16600  | Next

A Prospective Study of Long-Term Outcomes Among Hospitalized COVID-19 Patients with and without Neurological Complications
Frontera, J. A., Yang, D., Lewis, A., Patel, P., Medicherla, C., Arena, V., Fang, T., Andino, A., Snyder, T., Madhavan, M., Gratch, D., Fuchs, B., Dessy, A., Canizares, M., Jauregui, R., Thomas, B., Bauman, K., Olivera, A., Bhagat, D., Sonson, M., Park, G., Stainman, R., Sunwoo, B., Talmasov, D., Tamimi, M., Zhu, Y., Rosenthal, J., Dygert, L., Rustic, M., Ishii, H., Valdes, E., Omari, M., Gurin, L., Huang, J., Czseiler, B. M., Kahn, D. E., Zhou, T., Lin, J., Lord, A., Melmed, K., Meropol, S., Troxel, A., Petkova, E., Wisniewski, T., Balcer, L., Morrison, C., Yaghi, S., Galetta, S.
10.1101/2021.03.18.21253881 — Posted: 2021-03-20
The effects of physical distancing and lockdown to restrain SARS-CoV-2 outbreak in the Italian Municipality of Cogne
Gervino, G., Truc, F.
10.1101/2021.03.19.21253962 — Posted: 2021-03-20
Cancer services during the COVID-19 pandemic: systematic review of patients' and caregivers' experiences
Dhada, S., Stewart, D., Cheema, E., Hadi, M. A., Paudyal, V.
10.1101/2021.03.19.21253949 — Posted: 2021-03-20
Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patients
Schweizer, T. A., Mairpady Shambat, S., Vulin, C., Hoeller, S., Acevedo, C., Huemer, M., Gomez-Mejia, A., Chang, C.-C., Baum, J., Hertegonne, S., Hitz, E., Hofmaenner, D. A., Buehler, P. K., Moch, H., Schuepbach, R. A., Brugger, S. D., Zinkernagel, A. S.
10.1101/2021.03.19.436166 — Posted: 2021-03-19
Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro
Tran, H. T. T., Le, N. P. K., Gigl, M., Dawid, C., Lamy, E.
10.1101/2021.03.19.435959 — Posted: 2021-03-19
The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2, in vitro
Tateyama-Makino, R., Abe-Yutori, M., Iwamoto, T., Tsutsumi, K., Tsuji, M., Morishita, S., Kurita, K., Yamamoto, Y., Nishinaga, E., Tsukinoki, K.
10.1101/2021.03.19.435740 — Posted: 2021-03-19
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
Pohl, M. O., Busnadiego, I., Marrafino, F., Wiedmer, L., Hunziker, A., Fernbach, S., Omori, E., Hale, B. G., Caflisch, A., Silke, S.
10.1101/2021.03.19.435806 — Posted: 2021-03-19
Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19
Tang, J., Lee, Y., Ravichandran, S., Grubbs, G., Huang, C., Stauft, C., Wang, T., Golding, B., Golding, H., Khurana, S.
10.1101/2021.03.19.436183 — Posted: 2021-03-19
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
Perez-Gomez, A., Vitalle, J., Gasca-Capote, M. d. C., Gutierrez-Valencia, A., Trujillo-Rodriguez, M., Serna-Gallego, A., Munoz-Muela, E., Jimenez-Leon, M. d. l. R., Rafii-El-Idrissi Benhnia, M., Rivas-Jeremias, I., Sotomayor, C., Roca-Oporto, C., Espinosa, N., Infante-Dominguez, C., Crespo-Rivas, J. C., Fernandez-Villar, A., Perez-Gonzalez, A., Lopez-Cortes, L. F., Poveda, E., Ruiz-Mateos, E.
10.1101/2021.03.18.436001 — Posted: 2021-03-19
A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories
Fischer, B., Lichtenberg, C., Mueller, L., Timm, J., Fischer, J., Knabbe, C.
10.1101/2021.03.15.21253588 — Posted: 2021-03-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).